Chapter 4. Introduction to Anticancer Therapeutics
- Sotiris Missailidis
Published Online: 7 NOV 2008
DOI: 10.1002/9780470697047.ch4
Copyright © 2008 John Wiley & Sons, Ltd
Book Title

Anticancer Therapeutics
Additional Information
How to Cite
Boulikas, T. (2008) Introduction to Anticancer Therapeutics, in Anticancer Therapeutics (ed S. Missailidis), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470697047.ch4
Editor Information
Department of Chemistry and Analytical Sciences, The Open University, Milton Keynes, UK
Publication History
- Published Online: 7 NOV 2008
- Published Print: 21 NOV 2008
ISBN Information
Print ISBN: 9780470723036
Online ISBN: 9780470697047
- Summary
- Chapter
Keywords:
- cancer biology problems;
- anticancer therapeutics;
- tarceva and endothelial growth factor receptor (EGFR) inhibitor;
- proteins and RNAi (inhibitory RNA) - gene therapy targets;
- cancer problems and unmet needs;
- chemotherapy drug classification;
- cancer and existing and emerging biological therapies;
- vascular endothelial growth factor (bevacizumab) or EGFR (cetuximab)
Summary
This chapter contains sections titled:
Problems in cancer
Cancer treatments
Classification of chemotherapy drugs
